BDBM381853 3-(3-(2,3-Dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)-2,3-dihydro-1H-inden-5-yl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-2,2-dimethylpropanoic Acid, Formic Acid Salt::US10272095, Example 38

SMILES Cc1c(ccc2n(C)nnc12)C(c1ccc2CCC(N3CCOc4ccccc4C3)c2c1)C(C)(C)C(O)=O

InChI Key InChIKey=FKHRNDANIZIPLS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 381853   

TargetNAD(P)H dehydrogenase [quinone] 1(Human)
Glaxosmithkline

US Patent
LigandPNGBDBM381853(3-(3-(2,3-Dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)-2...)
Affinity DataEC50:  5.5nMAssay Description:NAD(P)H:quinone oxidoreductase 1 (NQO1), also called DT diaphorase, is a homodimeric FAD-containing enzyme that catalyzes obligatory NAD(P)H-dependen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent